A series of linear-chain complexes of molybdenum(II) acetate linked by bidentate bridging ligands, [Mo2(O2CCH3)4L]n (L = pyrazine (pyz), 4,4′ -bipyridine (4,4′-bpy), and 1,4-diazabicyclo[2.2.2]octane (dabco)), have been prepared, and their crystal structures determined by an X-ray diffraction method. It has been shown that the relatively weak coordinations of the bridging ligands at the axial positions of Mo2(O2CCH3)4 (Mo–N = 2.619 (8)—2.658(6) Å) can effectively control the arrangement of the dimer units to give chain structures with good linearities. No significant interactions between the dimer units have been observed.
No takes yet. Share an insight, caveat, or question.
Handa et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: